Expression and Characterization of Natural-Like Recombinant Der p 2 for Sublingual Immunotherapy-Reference-Cited by-同舟云学术

Expression and Characterization of Natural-Like Recombinant Der p 2 for Sublingual Immunotherapy

Published:2012 Issue:2 Volume:158 Page:157-167
ISSN:1423-0097
Container-title:International Archives of Allergy and Immunology
language:en
Short-container-title:Int Arch Allergy Immunol

Author:

Bordas-Le Floch Véronique,Bussières Laetitia,Airouche Sabi,Lautrette Aurélie,Bouley Julien,Berjont Nathalie,Horiot Stéphane,Huet Axelle,Jain Karine,Lemoine Pierrick,Chabre Henri,Batard Thierry,Mascarell Laurent,Baron-Bodo Véronique,Tourdot Sophie,Nony Emmanuel,Moingeon Philippe

Publisher

S. Karger AG

Subject

Immunology,General Medicine,Immunology and Allergy

Reference55 articles.

1. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5–grass pollen tablet for seasonal allergic rhinitis

2. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis

3. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis

4. Efficacy and safety of sublingual immunotherapy

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between protein conformational stability and its immunogenicity when administering antigens to mice using adjuvants—Analysis employed the CH2 domain in human antibodies;PLOS ONE;2024-07-22

2. Relationship between Protein Conformational Stability and Its Immunogenicity When Administering Antigens to Mice Using Adjuvants;2023-10-31

3. Current advances in house dust mite allergen immunotherapy (AIT): Routes of administration, biomarkers and molecular allergen profiling;Molecular Immunology;2023-03

4. A recombinant Der p 1-specific allergen-toxin demonstrates superior killing of allergen-reactive IgG+ hybridomas in comparison to its recombinant allergen-drug conjugate;Immunotherapy Advances;2022-12-06

5. Design, production and immunomodulatory potency of a novel allergen bioparticle;PLOS ONE;2020-12-01